Who is sponsoring NCT06930040?

NCT06930040 is sponsored by Kafrelsheikh University.

What drugs are being tested in NCT06930040?

Interventions in NCT06930040: Action observation therapy protocol, Kenisiotaping.

What condition does NCT06930040 study?

NCT06930040 studies Upper Extremity Function In Childern With Erb's Palsy.

Is NCT06930040 still recruiting?

NCT06930040 is currently completed. Last updated 15 August 2025.

Last reviewed 2025-08-15 · How we verify

NCT06930040

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Action Observation Therapy Versus Kinesio Taping on Upper Extremity Function In Children With Erb' Palsy

Completed NA Last updated 15 August 2025

What this trial tests

NA trial testing Action observation therapy protocol in Upper Extremity Function In Childern With Erb's Palsy in 38 participants. Completed in 1 July 2025.

Timeline

8 April 2025

Primary endpoint
18 April 2025

1 July 2025

Quick facts

Lead sponsor	Kafrelsheikh University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	38
Start date	8 April 2025
Primary completion	18 April 2025
Estimated completion	1 July 2025
Sites	1 location across Egypt

Drugs / interventions tested

Action observation therapy protocol
Kenisiotaping

Conditions studied

Upper Extremity Function In Childern With Erb's Palsy — all drugs for Upper Extremity Function In Childern With Erb's Palsy →

Sponsor

Kafrelsheikh University

Who can join

Adults 5 to 7, any sex, with Upper Extremity Function In Childern With Erb's Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to study the Effect of Action Observation Therapy versus Kinesiology Taping on upper extremity function In Erb\'s Palsy Children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kafrelsheikh University trials

Trials by the same sponsor.

NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06930040 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
Last refreshed: 15 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06930040.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing